Market Overview - The Australian Sharemarket saw a significant rally, with the S&P/ASX 200 closing at 9,014.80, up 147.40 points or 1.66%, marking a new 50-day high and the strongest close since late October 2025 [1][8] - The index has gained 0.97% over the last five days and is currently 1.10% off its 52-week high [2] Top Performers - AUSSIE BROADBAND LIMITED and AGL ENERGY LIMITED were the top performers, rising 14.79% and 11.75%, respectively [2][8] - Commonwealth Bank of Australia (CBA) rose 6.8% after reporting record first-half cash earnings, contributing to a 3.8% increase in heavyweight financials [3][8] Notable Stock Movements - Evolution Mining Limited (EVN) gained $1.300 to close at $16.280, an increase of 8.678% [6] - James Hardie Industries plc (JHX) advanced from $3.630 to $36.870, up 10.920% [8] - Domino's Pizza Enterprises shares rose 2.9% following the appointment of former McDonald's executive Andrew Gregory as CEO [9] Decliners - CSL Limited experienced the steepest decline, falling from $20.200 to $163.440, a drop of 11.000% [6][8] - Biotech major CSL slumped 18.2% to an eight-year low due to CEO Paul McKenzie's departure and a significant drop in half-year profit, impacting healthcare stocks which fell as much as 6.2% [8][9] - ResMed Inc. (RMD) slipped $1.760 to $36.790, down 4.566% [6]

Third Quarter FY26 Earnings Presentation Tuesday, February 10th 1 Q3 FY26 EARNINGS PRESENTATION Q3 FY26 EARNINGS PRESENTATION Q3 FY26 EARNINGS PRESENTATION Cautionary Note and Use of Non-GAAP Measures This Earnings Presentation contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. James Hardie Industries plc (the "Company") may from time to time make forward-looking statements in its periodic reports filed with or furnished to the Securities and Exch ...

Core Viewpoint - Australian Foundation Investment Co Ltd (AFIC) has reported its HY26 results, highlighting a special dividend and underperformance in its investment portfolio [1][10]. HY26 Result - The half-year net profit for AFIC was $147 million, reflecting a 5% decrease [10]. - The portfolio return for the half-year was negative 2%, compared to a positive 4.2% for the benchmark [10]. - The interim dividend per share was maintained at $0.12, with a special dividend of $0.025 per share [10]. Investment Performance - Several long-term holdings, including CSL Ltd, ARB Corporation Ltd, James Hardie Industries plc, Reece Ltd, and CAR Group Ltd, underperformed the market [3]. - Sectors that AFIC typically avoids, such as small and medium-sized resource shares, saw significant gains, with one-year returns of 73% and 104.3%, and gold up 127% [4]. Portfolio Management - AFIC has been reducing its positions in Wesfarmers Ltd and Commonwealth Bank of Australia, citing them as "extremely over-valued" [5]. - The company sold shares in Westpac Banking Corp, National Australia Bank Ltd, Netwealth Group Ltd, WiseTech Global Ltd, and James Hardie [5]. - AFIC focused its buying on Woolworths Group Ltd and Telstra Group Ltd, which it views as having attractive dividend yields and valuations [6]. International Portfolio - AFIC's international portfolio has grown to $170 million from an initial investment of $103.5 million in May 2021, with plans to maintain a concentrated portfolio rather than listing a separate fund [7]. Market Outlook - AFIC perceives the market as expensive, particularly regarding long-term averages for price-to-earnings ratios and dividend yields [8]. - The company believes it can capitalize on buying opportunities in selected high-quality companies with promising long-term growth prospects [8]. Investment Stability - AFIC is considered one of the most stable ASX dividend shares due to its diversified portfolio [11].

Core Viewpoint - James Hardie Industries plc is optimizing its manufacturing footprint by closing two US facilities, which is expected to enhance efficiency and generate significant cost savings [1][2][3]. Group 1: Manufacturing Operations - The company will close its manufacturing facilities in Fontana, California, and Summerville, South Carolina, within the next 60 days, which represent approximately 6% of its year-to-date North American volume [2]. - The innovation and research & development functions at the Fontana site will continue to operate despite the closures [2]. Group 2: Cost Savings and Financial Impact - The closures are projected to yield annualized cost savings of around $25 million starting in the first quarter of FY27, driven by reduced fixed costs and improved utilization across the remaining manufacturing network [3]. - A one-off charge of $40 million to $44 million will be incurred, primarily related to employee severance, benefits, transition costs, and asset impairments [4]. Group 3: Management Commentary - The CEO emphasized the importance of modernizing manufacturing facilities to improve efficiency and support growth initiatives, indicating a strategic shift towards advanced plants [5]. - The decision to close the plants was made after careful consideration, acknowledging the contributions of the teams at these sites [6]. Group 4: Market Position and Investor Sentiment - The share price has recovered some losses from the past year, indicating a potential regain of investor confidence, although the company may not be considered a bargain at current levels [7].

Core Viewpoint - The complaint alleges that James Hardie Industries plc misled investors regarding the performance of its North America Fiber Cement segment, leading to significant financial losses for investors [2]. Group 1: Allegations and Financial Impact - The company and its executives are accused of violating federal securities laws by making false statements and failing to disclose inventory destocking by distributors between May 20 and August 18, 2025 [2]. - On August 19, 2025, James Hardie reported a 29% decline in first-quarter profit and projected lower-than-expected earnings for fiscal 2026 due to high borrowing costs [2]. - Following the announcement, the price of James Hardie's American Depositary Receipt (ADR) fell by $9.79, or 34.44%, closing at $18.64 per ADR on August 20, 2025 [3]. Group 2: Legal Proceedings - The lead plaintiff in the class action is the investor with the largest financial interest in the case, who will oversee the litigation on behalf of the class [4]. - Any member of the putative class can apply to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [4]. Group 3: Call for Information - The law firm Faruqi & Faruqi encourages individuals with information regarding James Hardie's conduct, including whistleblowers and former employees, to come forward [5].

Core Viewpoint - A class action lawsuit has been filed against Skye Bioscience, Inc. for alleged violations of securities laws, specifically related to misleading statements about its drug candidate, nimacimab, and its commercial prospects [1][4]. Group 1: Lawsuit Details - The lawsuit pertains to investors who purchased Skye's securities between November 4, 2024, and October 3, 2025, and encourages them to contact the Schall Law Firm before January 16, 2026 [2]. - The complaint alleges that Skye made false and misleading statements regarding the effectiveness of nimacimab and overstated its commercial and clinical prospects [4]. Group 2: Investor Impact - Investors suffered damages when the truth about Skye's drug candidate and its market position was revealed [4]. - The Schall Law Firm specializes in securities class action lawsuits and represents investors globally [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against MoonLake Immunotherapeutics due to allegations of violations of federal securities laws, particularly following disappointing clinical trial results that led to a significant drop in the company's stock price [2][3][4]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses exceeding $75,000 in MoonLake between March 10, 2024, and September 29, 2025, to discuss their legal options [1][2]. - A federal securities class action has been filed against MoonLake, with a deadline of December 15, 2025, for investors to seek the role of lead plaintiff [2][5]. Group 2: Allegations Against MoonLake - The complaint alleges that MoonLake and its executives made false or misleading statements regarding the efficacy of their product SLK compared to BIMZELX, including claims about molecular targets and clinical benefits [3]. - Specific allegations include that SLK shares the same molecular targets as BIMZELX and that its unique structure does not provide superior clinical benefits [3]. Group 3: Stock Price Impact - Following the announcement of the Phase 3 VELA program results on September 28, 2025, which indicated that SLK did not demonstrate competitive efficacy relative to BIMZELX, MoonLake's stock price fell by $55.75 per share, or 89.9%, closing at $6.24 on September 29, 2025 [4].

Group 1 - The 2025 Annual General Meeting of James Hardie Industries plc is being conducted with a focus on orderly and efficient proceedings [1] - Shareholder questions are limited to two per topic and must relate strictly to the agenda items [2] - Media representatives are not allowed to ask questions during the meeting, and inquiries should be directed to investor relations post-meeting [3]

Core Viewpoint - James Hardie Industries plc has experienced a 10% increase in share price following a positive quarterly update, indicating strong market confidence in the company's performance and outlook [1]. Financial Performance - The company anticipates net sales for the quarter ending September 30, 2025, to be between $1.29 billion and $1.3 billion [2]. - Adjusted EBITDA is expected to range from $326 million to $331 million, while adjusted net income is projected to be between $151 million and $157 million, with adjusted earnings per share (EPS) estimated at $0.26 to $0.27 [2]. Debt and Sales Insights - As of September 30, 2025, James Hardie's net debt stood at $4.5 billion [3]. - Although siding and trim sales exceeded expectations, organic net sales showed a low single-digit decline compared to the previous year, and inventory reductions by distributors and dealers were less than anticipated [3]. Market Conditions - The company acknowledges challenges in single-family new construction but emphasizes the commitment of customers to product availability, highlighting the strength of its brand and partnerships [4]. Management Commentary - CEO Aaron Erter expressed optimism regarding the second quarter results and noted a modest improvement in the outlook for Siding & Trim, with a full-year guidance update expected in November [5]. Integration and Growth Opportunities - The integration of AZEK and synergy capture initiatives are progressing well, with AZEK reporting mid-single-digit growth in net sales and sell-through for Deck, Rail & Accessories compared to the prior year [6]. - The upcoming fiscal third quarter is crucial for planning shelf space for the next selling season, presenting opportunities to expand James Hardie Siding & Trim into AZEK's dealer network [6][7]. Shareholder Sentiment - Shareholders are likely pleased with the recent update, although the stock remains over 40% lower than its value in March 2024, indicating potential cyclical investment opportunities [8].

Core Viewpoint - James Hardie Building Products Inc. reaffirms its commitment to affordable housing and climate-resilient communities through sponsorship of Habitat for Humanity's initiatives, particularly the 2025 Jimmy & Rosalynn Carter Work Project [1][4][5] Group 1: Commitment to Affordable Housing - James Hardie is sponsoring Habitat for Humanity's 2025 Jimmy & Rosalynn Carter Work Project in Austin, Texas, focusing on building safe and affordable homes [4] - The company emphasizes its purpose of "Building a Better Future for All" by creating lasting impacts in neighborhoods across the country [3][4] Group 2: Habitat Strong Initiative - The Habitat Strong initiative aims to develop climate-resilient housing that withstands extreme weather while remaining affordable and energy-efficient [5] - James Hardie's durable products, which are noncombustible and resilient against moisture and pests, play a crucial role in these housing projects [5][8] Group 3: Community Engagement and Fundraising - James Hardie engages its employees as volunteers in Habitat Strong projects, enhancing its impact on local communities [4] - The company also hosts the annual James Hardie Pro Football Hall of Fame Invitational, which raises funds for Habitat for Humanity, contributing to affordable housing initiatives [6]